| CRK proto-oncogene maps to human chromosome band 17p13. | None |
| The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. | None |
| The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling. | None |
| Emerging components of the Crk oncogene product: the first identified adaptor protein. | None |
| The proto-oncogene Crk-II enhances apoptosis by a Ras-dependent, Raf-1/MAP kinase-independent pathway. | None |
| Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor. | None |
| Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction. | None |
| Role of Crk oncogene product in physiologic signaling. | None |